GVHD and the role of the dermatologist
Episode notes
As the largest organ in the body, the skin is commonly impacted by graft-versus-host disease (GVHD). What are the treatment approaches to manage GVHD of the skin?
Our host, Dr. Gizelle Popradi, is joined by Dr. Ivan Litvinov, a dermatologist with the McGill University Health Centre in Montreal, to discuss this topic and more.
In this episode, Dr. Litvinov introduces the role of dermatologists and their importance on the stem cell transplant team in the initial assessment and follow-up of patients with GVHD, particularly those taking photosensitizing medications. The varying manifestations and severity of skin GVHD are also discussed, including treatment approaches best suited for each manifestation. Lastly, Dr. Litvinov provides a list of best practices and advice for patients.
Don’t miss the conversation!
The views and opinions expressed in this episode are those of the speakers and do not necessarily reflect the views or positions of any entities they represent.
Declaration of conflict of interest:
Dr. Gizelle Popradi:
- Direct financial relationship including receipt of honoraria: Sanofi, Servier, Mallinckrodt, AbbVie, Jazz, Medexus, Pfizer, Seattle Genetics, Takeda, Amgen, Merck, Gilead, Novartis, Kyowa Kirin, Paladin, Sobi. Funded grants, research, or clinical trials: Mallinckrodt, Syndax, AbbVie, Equillium, Amgen, Incyte.
Dr. Ivan Litvinov:
- None
MAT-CA-2400942